EBS — Emergent BioSolutions Inc.
$5.79
$-0.10 (-1.70%)
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments.
Market Cap
$297.69M
Forward P/E
5.5x
52-Week Range
N/A
EBS Price History
Revenue vs. Net Income
$743M
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$157M
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
12.0%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.7x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
1.9%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+7.0%
Dilution · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
